• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

Greene calls for yanking FDA approval of COVID-19 vaccines: ‘Causing permanent harm and deaths’

by March 21, 2025
written by March 21, 2025

Rep. Marjorie Taylor Greene, R-Ga., declared that U.S. Food and Drug Administration approval for COVID-19 vaccines should be yanked, asserting that the jabs ‘are causing permanent harm and deaths.’

‘FDA approval for COVID-19 vaccines needs to be pulled and they need taken off the childhood vaccine schedule ASAP,’ she said Thursday in a post on X. ‘I’ve been saying this ever since they were created and my personal Twitter account was permanently banned for my outspoken stance against the vaccines until Elon Musk bought Twitter, changed it to X, and restored my account along with thousands of people who were censored and silenced.’

The child and adolescent immunization schedule on the Centers for Disease Control and Prevention website includes COVID-19 vaccine recommendations for children 6 months old and above.

Greene contends that the jabs should never have been approved in the first place.

‘COVID-19 vaccines should have never received approval and they’ve known the entire time how bad the side effects are and deaths caused by them. It’s time to do the right thing. Stop the COVID-19 vaccines,’ she declared in her post.

But the CDC notes, ‘COVID-19 vaccination is recommended for everyone ages 6 months and older in the United States for the prevention of COVID-19. There is currently no FDA-approved or FDA-authorized COVID-19 vaccine for children younger than age 6 months. CDC recommends that people stay up to date with COVID-19 vaccination.’

‘Cases of myocarditis and pericarditis have rarely been observed following receipt of COVID-19 vaccines used in the United States,’ the CDC indicates.

‘Evidence from multiple monitoring systems support a causal association for mRNA COVID-19 vaccines (Moderna or Pfizer-BioNTech) and myocarditis and pericarditis. Cases have occurred most frequently in adolescent and young adult males within 7 days after receiving the second dose of an mRNA COVID-19 vaccine (Moderna and Pfizer-BioNTech); however, cases have also been observed in females and after other doses.’

Rep. Thomas Massie has also expressed the view that the FDA should nix approval for the COVID-19 vaccines. 

‘FDA should immediately revoke approval of these shots,’ he tweeted last month.

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
Bernie Sanders, AOC take aim at Trump and Musk, as well as Democrats, at western rallies
next post
Trump’s hostage envoy Boehler met with Taliban in Kabul in first in-person meeting since takeover

related articles

DHS scorches Pritzker’s ‘sanctuary’ state after child rapist...

May 1, 2026

Socialist mayor’s blunt 1-word message to fleeing millionaires...

May 1, 2026

DC police captain cites bodycam footage of officers...

May 1, 2026

Amazon explores ‘The Apprentice’ reboot with Trump Jr...

May 1, 2026

MN governor race to replace Walz sees major...

May 1, 2026

Trump’s apocalyptic Iran warning raises stakes for sweeping...

April 7, 2026

Graham eyes ‘down payment’ on Trump-backed SAVE Act...

April 7, 2026

Democrat whose parents fled Iran moves to oust...

April 7, 2026

Midterm alarm bells: Democrats face steep favorability deficit...

April 7, 2026

American journalist kidnapped in Iraq is set free,...

April 7, 2026
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • Gold and Silver: New Higher Targets and Prices on Friday

    October 4, 2024
  • ‘Orange Man’ Trump will jail protesters, Jane Fonda claims at Harris event for overseas voters

    September 6, 2024
  • Israel strikes at the heart of Iran’s nuclear ambitions in Isfahan offensive

    June 14, 2025
  • Harris’ mixed record on Israel enters spotlight during Netanyahu visit

    July 24, 2024
  • Trump budget bill extending first-term tax cuts survives House vote

    February 26, 2025

Popular Posts

  • 1

    District judges’ orders blocking Trump agenda face hearing in top Senate committee

    April 2, 2025
  • 2

    Secret Service admits leaning on ‘state and local partners’ after claim it ignored Trump team’s past requests

    July 21, 2024
  • 3

    Five more House Democrats call on Biden to drop out, third US senator

    July 19, 2024
  • 4

    CoreWeave eyes $1.5B bond raise to ease debt load following lacklustre IPO: report

    May 9, 2025
  • 5

    Forex Profit Calculator: Maximize Your Trading Potential

    July 10, 2024

Categories

  • Economy (829)
  • Editor's Pick (8,507)
  • Investing (2,492)
  • Stock (1,028)

Latest Posts

  • Amazon’s Zoox robotaxi unit issues software recall after recent Las Vegas crash

    May 6, 2025
  • Cardi B suffers teleprompter glitch during Harris rally in Wisconsin

    November 2, 2024
  • Trump ally Bukele’s party amends El Salvador constitution to allow indefinite presidential re-election

    August 1, 2025

Recent Posts

  • Trump picks former intel director John Ratcliffe to head the CIA

    November 13, 2024
  • The 2024 Republican National Convention: What to know

    July 14, 2024
  • Nasdaq, Dow jump on peace prospects; Powell pivot fuels Q1 finale

    March 31, 2026

Editor’s Pick

  • House Freedom Caucus embraces Trump budget proposal ‘paradigm shift’

    May 2, 2025
  • Former Trump co-defendants want judge to block Special Counsel Jack Smith report

    January 7, 2025
  • Voters react to Gov. Tim Walz claiming abortion is a ‘basic human right’

    October 2, 2024
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock